Optimus Pharma Private Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Optimus Pharma Private Limited - overview
Established
2004
Location
Hyderabad, Telangana, India
Primary Industry
Pharmaceuticals
About
Founded in 2004 and based in Telangana, India, Optimus Pharma Private Limited operates as a manufacturing company that manufactures pharmaceutical products. The company was founded by Srinivas Reddy. In September 2022, a consortium led by PAG, including CX Partners and Samara Capital, acquired a controlling stake in Optimus Pharma Pvt. Ltd.
for INR 2000 crore. The transaction value for Optimus Pharma Pvt. Ltd. is INR 13.
57 billion. As of 2024, the company is led by its CEO, Kanwal Pandita. Optimus Pharma develops active pharmaceutical ingredients (APIs) and advanced drug intermediates for the pharmaceutical industry. The firm’s product line includes Aminocaproic acid, Amorolfine, Apixaban, Bempedoic acid, Bilastine, Bucillamine, D-Penicillamine, Dapagliflozin amorphous, Dapagliflozin propanediol, Dabigatran Etexilate Mesylate, Dapoxetine, Dexlansoprazole, Dimethyl Fumarate, Dithranol, Eberconazole Nitrate, Eletriptan Hydrobromide, Empagliflozin, Ethacizine Hydrochloride, Brivaracetam, Dabigatran Etexilate capsules, Rifaximin tablets, and Rivaroxaban tablets.
Current Investors
PAG, Samara Capital, CX Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.optimuspharma.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Optimus Pharma Private Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Optimus Pharma Private Limited | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.